What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment

1-855-528-7248

Current Patients

1-206-306-2800

Physician Line

1-888-987-7782

Read our Covid-19 policy

Clinical Studies

Filter By:

Reirradiation of thoracic cancers with intensity modulated proton therapy Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Liao Z, Zhu XR, Gomez D, Lin SH, Gillin M, Komaki R, Hahn S, Chang JY Lung and Thoracic Cancers Read Study
Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging Shusharina N, Liao Z, Mohan R, Liu A, Niemierko A, Choi N, Bortfeld T Lung and Thoracic Cancers Read Study
Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients Jakobi A, Perrin R, Knopf A, Richter C Lung and Thoracic Cancers Read Study
Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer Ono T, Nakamura T, Yamaguchi H, Azami Y, Takayama K, Suzuki M, Wada H, Kikuchi Y, Murakami M, Nemoto K Lung and Thoracic Cancers Read Study
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study Jeter MD, Gomez D, Nguyen QN, Komaki R, Zhang X, Zhu X, O'Reilly M, Fossella FV, Xu T, Wei X, Wang H, Yang W, Tsao A, Mohan R, Liao Z Lung and Thoracic Cancers Read Study
Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study Wink KCJ, Roelofs E, Simone CB, Dechambre D, Santiago A, van der Stoep J, Dries W, Smits J, Avery S, Ammazzalorso F, Jansen N, Jelen U, Solberg T, de Ruysscher D, Troost EGC Lung and Thoracic Cancers Read Study
Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy Lee H, Zeng J, Bowen SR, Rengan R Lung and Thoracic Cancers Read Study
Prospective Study of Proton-Beam Radiation Therapy for Limited-Stage Small Cell Lung Cancer Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd Lung and Thoracic Cancers Read Study
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small-Cell Lung Cancer Final Results of a Phase 2 Study Chang JY, Verma V, Li M, et. al. Lung and Thoracic Cancers Read Study
Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes McAvoy S1, Ciura K1, Wei C1, Rineer J1, Liao Z1, Chang JY1, Palmer MB1, Cox JD1, Komaki R1, Gomez DR2. Lung and Thoracic Cancers Read Study
High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study Oshiro Y1, Okumura T1, Kurishima K2, Homma S2, Mizumoto M1, Ishikawa H1, Onizuka M3, Sakai M3, Goto Y3, Hizawa N2, Sato Y3, Sakurai H4 Lung and Thoracic Cancers Read Study
Accelerated dose escalation with proton beam therapy for non-small cell lung cancer Gomez DR, Chang JY. Lung and Thoracic Cancers Read Study
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer Kanemoto A1, Okumura T2, Ishikawa H2, Mizumoto M2, Oshiro Y2, Kurishima K3, Homma S3, Hashimoto T2, Ohkawa A2, Numajiri H2, Ohno T2, Moritake T2, Tsuboi K2, Sakae T2, Sakurai H2. Lung and Thoracic Cancers Read Study
Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH. Lung and Thoracic Cancers Read Study
Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Lung and Thoracic Cancers Read Study
High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center Bush DA, Cheek G, Zaheer S, Wallen J, Mirshahidi H, Katerelos A, Grove R, Slater JD. Lung and Thoracic Cancers Read Study